Helier Scientific Limited (HSL) was established in 2004 initially to commercialise methods and ideas developed by scientists and clinicians working in the South West Thames institute for renal research and in particular the measurement of urinary and serum biomarkers. In addition HSL carries out a number of specialist services including the novel patented finger prick GFR device for measuring true glomerular filtration rate in a more accessible and patient friendly manner. The Company also offers xMAP assays for measuring a range of growth factors, cytokines and chemokines extracted from tissue, urine and blood. HSL is proud to provide a water testing service to local hospitals and home dialysis patients.
HSL now supplies products previously developed by PPR Diagnostics Ltd. Its scientists have pioneered the use of a Calibrant based colorimetric diagnostic kits for the enzyme NAG one of the earliest known early biomarker for acute kidney injury resulting from nephrotoxic drugs, environmental pollutants or renal disease. A novel range of chromogenic substrates developed by PPR have been incorporated in chromogenic media for Candia species, Salmonella, E. coli and Mycoplasma agalactiae and bovis. HSL can now supply highly purified Diphencyprone to pharmacies and dermatologists. This compound is used for the treatment of Alopecia, recalcitrant warts and certain types of Melanoma. HSL is currently developing a rapid Point of care test for urinary tract infection.
Working in association with The South West Thames Institute for Renal Research and The Royal Society of Chemistry.
The company has Trademarks RapichromeTM Community Trade Mark No 005285333, Trademark USA No. 3495042 (2008) and GRAMBACTORTM UK and EU Trademark No 012552899.